Phase 1 Part A - dose escalation TYRA-200 taken once daily by mouth in 28-day cycles
TYR200-101
Phase 1 small_molecule active
Quick answer
Phase 1 Part A - dose escalation TYRA-200 taken once daily by mouth in 28-day cycles for Locally Advanced Cholangiocarcinoma is a Phase 1 program (small_molecule) at Tyra Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tyra Biosciences
- Indication
- Locally Advanced Cholangiocarcinoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active